Key facts
- MEDIROM MOTHER Labs’s last known valuation is $62.4M (Oct 2025).
- It has raised $1.8M; the latest was Early Stage VC ($1.8M) in Oct 2025.
- Notable investors include Elematec, M3, NFES Technologies.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for MEDIROM MOTHER Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for MEDIROM MOTHER Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MEDIROM MOTHER Labs
Operator of a health technology company headquartered in Tokyo, Japan. The company provides a wearable tracker for continuous activity monitoring without the need for lifelong charging, alongside a healthcare application, allowing users to effortlessly track their physical condition and activity history while receiving personalized coaching from healthcare professionals like registered dietitians, physiotherapists, and occupational therapists via chat.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2023
- Employees
- 50
- Website
- medirom-mother-labs.co.jp/
- Ownership
- Privately Held (backing)
MEDIROM MOTHER Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MEDIROM MOTHER Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MEDIROM MOTHER Labs in its N-PORT filings yet. We sweep new filings monthly.